Join Us at AES 2022

December 2-6 | Nashville, Tennessee

NeuroPace Events at AES

Closing the Epilepsy Treatment Gap: Old Challenges, New Opportunities

SATELLITE SYMPOSIUM

Closing the Epilepsy Treatment Gap:
Old Challenges, New Opportunities

Featuring:
Dr. Fedor Panov and Dr. Patrick Landazuri

Sunday, December 4 from 6:00-9:00pm CT

REGISTER HERE

People networking at an event

FELLOWS NETWORKING RECEPTION

Advanced Neuromodulation Technology & Post‑Fellowship Advice

Featuring:
Dr. Danielle Becker and Dr. Deepak Madhavan

Friday, December 2 from 6:00-8:00pm CT

REGISTER HERE

Screenshot of a tablet app

HANDS-ON RNS SYSTEM PROGRAMMING WORKSHOP

Get hands-on RNS System programming training and learn how Simple Set Programming can streamline your clinic experience.

Saturday, December 3 – Monday, December 5th (60 ‑ 90 minutes)

REGISTER HERE

CAUTION—Investigational device. Limited by United States law to investigational use for the following Indications for Use: The RNS® System is intended for thalamic stimulation as an adjunctive therapy for the treatment of primary generalized seizures in individuals 12 years of age or older who have drug-resistant idiopathic generalized epilepsy.

*The median battery longevity is 10.8 years, on average, for the RNS Neurostimulator (model RNS-320). Estimates for longevity were derived from medium stimulation utilization (mAh/day).

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci. See important prescribing and safety information at https://www.neuropace.com/safety/.

©2022 NeuroPace, Inc. All rights reserved. NeuroPace, RNS, and Window to the Brain are registered trademarks of NeuroPace, Inc. NP 220137 Rev 2 / Rev date: 2022-11